Replies to post #8209 on Momenta Pharmaceuticals, Inc. (MNTA)

[oldberkeley]

UBS raised its price target on MNTA from 19 to 22.

$17, $16, $19, $22....I probably missed some stops along the way.

IMHO it just emphasizes how silly and useless these analyst targets are.